Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 4:27 AM
Ignite Modification Date:
2025-12-25 @ 4:27 AM
NCT ID:
NCT01762020
Eligibility Criteria:
Inclusion Criteria:
* Female patients between 18 and 80 years of age at the time of enrollment
* Histopathologically or cytologically confirmed diagnosis of breast cancer
* Completed lumpectomy and sentinel lymph node biopsy or axillary lymph node dissection
* Signed and dated ethics-approved informed consent form prior to any study procedures
* Ability to comply with the requirements of the study
* Scheduled adjuvant radiation therapy treatment
Exclusion Criteria:
* Clinical or radiological evidence of local recurrence or metastatic disease
* Previous history of radiation therapy to ipsilateral axilla and/or breast area
* Planned boost of radiation Dementia, psychoses, or other significant impairment of mental status that would prohibit the understanding and giving of informed consent or the participation in self-care or toxicity reporting
* Any significant history or concurrent disease which, in the judgment of the Investigator would make the patient inappropriate for entry to this study
* History of contraindications of radiation such as scleroderma
Healthy Volunteers:
False
Sex:
FEMALE
Minimum Age:
18 Years
Maximum Age:
80 Years
Study:
NCT01762020
Study Brief:
Protocol Section:
NCT01762020